{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:50:38Z","timestamp":1790628638769,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014801","name":"Ankara Yildirim Beyazit University","doi-asserted-by":"publisher","award":["TSA-2022-2365"],"award-info":[{"award-number":["TSA-2022-2365"]}],"id":[{"id":"10.13039\/501100014801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.leukres.2024.107636","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T19:33:03Z","timestamp":1734550383000},"page":"107636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The relationship between clinical prognostic factors, microvascular density, and tumor-infiltrating lymphocytes with CD47 and SIRP\u03b1 expression in diffuse large B cell lymphomas"],"prefix":"10.1016","volume":"149","author":[{"given":"Aydan","family":"K\u0131l\u0131\u00e7arslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevdenur \u00d6zd\u00fczg\u00fcn","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayriye Tatl\u0131","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011fba Dilay K\u00f6kenek","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eefika","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcls\u00fcm","family":"\u00d6zet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.leukres.2024.107636_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1586\/era.09.170","article-title":"Unresolved issues in diffuse large B-cell lymphomas","volume":"10","author":"Murawski","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"19","key":"10.1016\/j.leukres.2024.107636_bib2","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"2-3","key":"10.1016\/j.leukres.2024.107636_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.seminoncol.2020.05.009","article-title":"Just eat it: a review of CD47 and SIRP-alpha antagonism","volume":"47","author":"Oronsky","year":"2020","journal-title":"Semin. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107636_bib4","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.4049\/jimmunol.167.5.2547","article-title":"Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation","volume":"167","author":"Latour","year":"2001","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107636_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12527","article-title":"The CD47-SIRPalpha signaling axis as an innate immune checkpoint in cancer","volume":"276","author":"Matlung","year":"2017","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.leukres.2024.107636_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40364-023-00456-x","article-title":"The landscape overview of CD47-based immunotherapy for hematological malignancies","volume":"11","author":"Yang","year":"2023","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.leukres.2024.107636_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41408-023-00930-7","article-title":"Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models","volume":"13","author":"Jelicic","year":"2023","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.leukres.2024.107636_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13045-020-00930-1","article-title":"Role of CD47 in hematological malignancies","volume":"13","author":"Eladl","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2024.107636_bib9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.leukres.2014.09.007","article-title":"Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma","volume":"38","author":"Marinaccio","year":"2014","journal-title":"Leuk. Res"},{"key":"10.1016\/j.leukres.2024.107636_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107636_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2024.107636_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100750","article-title":"How I treat diffuse large B-cell lymphoma","volume":"8","author":"Melchardt","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.leukres.2024.107636_bib13","unstructured":"R. KazamaH. MiyoshiM. Takeuchiet al.Combination of CD47 and signal-regulatory protein-alpha constituting the \u201cdon\u2019t eat me signal\u201d is a prognostic factor in diffuse large B-cell lymphomaCancer Sci.111720202608261910.1111\/cas.14437."},{"issue":"5","key":"10.1016\/j.leukres.2024.107636_bib14","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.4049\/jimmunol.1103606","article-title":"Endothelial CD47 promotes vascular endothelial-cadherin tyrosine phosphorylation and participates in T cell recruitment at sites of inflammation in vivo","volume":"189","author":"Azcutia","year":"2012","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107636_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bjh.18137","article-title":"Checkpoint CD47 expression in classical Hodgkin lymphoma","volume":"197","author":"Gholiha","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"13","key":"10.1016\/j.leukres.2024.107636_bib16","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.7150\/ijbs.60782","article-title":"CD47\/SIRPalpha pathway mediates cancer immune escape and immunotherapy","volume":"17","author":"Jia","year":"2021","journal-title":"Int J. Biol. Sci."},{"issue":"25","key":"10.1016\/j.leukres.2024.107636_bib17","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.leukres.2024.107636_bib18","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.leukres.2024.107636_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.pathol.2020.12.003","article-title":"Genomic characterisation of diffuse large B-cell lymphoma","volume":"53","author":"Harrington","year":"2021","journal-title":"Pathology"},{"issue":"24","key":"10.1016\/j.leukres.2024.107636_bib20","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1182\/bloodadvances.2021006305","article-title":"CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain","volume":"6","author":"Cho","year":"2022","journal-title":"Blood Adv."},{"issue":"11","key":"10.1016\/j.leukres.2024.107636_bib21","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/jnr.22076","article-title":"Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro","volume":"87","author":"Xing","year":"2009","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.leukres.2024.107636_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117426","article-title":"Is CD47 a potentially promising therapeutic target in cardiovascular diseases? - Role of CD47 in cardiovascular diseases","volume":"247","author":"Cheng","year":"2020","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.leukres.2024.107636_bib23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1681\/ASN.2013040433","article-title":"Thrombospondin-1 activation of signal-regulatory protein-alpha stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury","volume":"25","author":"Yao","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107636_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051257","article-title":"Tumor microenvironment and microvascular density in follicular lymphoma","volume":"11","author":"Tamma","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.leukres.2024.107636_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00277-018-3534-z","article-title":"Novel risk stratification of de novo diffuse large B cell lymphoma based on tumour-infiltrating T lymphocytes evaluated by flow cytometry","volume":"98","author":"Chen","year":"2019","journal-title":"Ann. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2024.107636_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/ejh.13484","article-title":"Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma","volume":"105","author":"Pollari","year":"2020","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107636_bib27","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2141.2001.02649.x","article-title":"Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study","volume":"112","author":"Xu","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107636_bib28","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood-2008-01-134429","article-title":"Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro","volume":"112","author":"Stefanidakis","year":"2008","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:37:21Z","timestamp":1778668641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":28,"alternative-id":["S0145212624002029"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107636","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between clinical prognostic factors, microvascular density, and tumor-infiltrating lymphocytes with CD47 and SIRP\u03b1 expression in diffuse large B cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107636"}}